ARTICLE | Company News
Biovation, Centocor protein deal
July 7, 2003 7:00 AM UTC
Biovation (Aberdeen, U.K.), a Merck KGaA (FSE:MRK) company, will apply its DeImmunisation technology to undisclosed therapeutic proteins from Centocor. DeImmunisation technology is designed to elimina...